- 2025,07,17
Securities Star News: Sincere Pharmaceutical (603811) responded to investors' concerns on the investor relations platform on June 26th.
Investor：Has the company's performance been explosive? The market value has been continuously declining
Sincere Pharmaceutical Board Secretary：Thank you for your attention! The company is operating well with steady growth in performance. The company's stock price is influenced by various factors such as international situation, macroeconomic, industry policies, market capital trends, and investor risk preferences. Please make cautious decisions and pay attention to investment risks. At the same time, the company will continue to improve its profitability and sustainable development capabilities, promote value growth, and create more returns for shareholders. The company has released its 2024 annual report and 2025 first quarter report on April 30, 2025. Please refer to the website of the Shanghai Stock Exchange for specific data content. thank you!
The above content is compiled from publicly available information by Securities Star and generated by AI algorithms (Network Information Calculation Record No. 310104345710301240019), and does not constitute investment advice.
Reprinted From: Tencent Micro Securities Mini Program - Zhengxing Secretary Interactive